{
  "trial_id": "NCT02804750",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, body mass index (BMI), baseline cortisol levels, duration of Cushing's syndrome, presence of type 2 diabetes mellitus, presence of impaired glucose tolerance, presence of hypertension, baseline blood pressure, baseline glucose levels, renal function (e.g., creatinine levels), thyroid function (e.g., TSH levels).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Hypertension",
          "presence of hypertension"
        ],
        [
          "Impaired Glucose Tolerance (IGT) / Type-2 Diabetes Mellitus (T2DM)",
          "presence of type 2 diabetes mellitus"
        ],
        [
          "Impaired Glucose Tolerance (IGT) / Type-2 Diabetes Mellitus (T2DM)",
          "presence of impaired glucose tolerance"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "baseline cortisol levels",
        "duration of Cushing's syndrome",
        "baseline blood pressure",
        "baseline glucose levels",
        "renal function (e.g., creatinine levels)",
        "thyroid function (e.g., TSH levels)"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Type 2 Diabetes Mellitus Status, Impaired Glucose Tolerance Status, Hypertension Status, Baseline Cortisol Levels,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Hypertension",
          "Hypertension Status"
        ],
        [
          "Impaired Glucose Tolerance (IGT) / Type-2 Diabetes Mellitus (T2DM)",
          "Type 2 Diabetes Mellitus Status"
        ],
        [
          "Impaired Glucose Tolerance (IGT) / Type-2 Diabetes Mellitus (T2DM)",
          "Impaired Glucose Tolerance Status"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Baseline Cortisol Levels"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Diabetes Status, Hypertension Status, Glucose Tolerance Status, Cortisol Levels, Duration of Cushing's Syndrome.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Hypertension",
          "Hypertension Status"
        ],
        [
          "Impaired Glucose Tolerance (IGT) / Type-2 Diabetes Mellitus (T2DM)",
          "Diabetes Status"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Glucose Tolerance Status",
        "Cortisol Levels",
        "Duration of Cushing's Syndrome."
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of Cushing's syndrome, type of Cushing's syndrome (e.g., pituitary, adrenal, ectopic), presence of type 2 diabetes mellitus, impaired glucose tolerance, hypertension, history of hypothyroidism or hyperthyroidism, renal function (e.g., estimated glomerular filtration rate), prior treatments for Cushing's syndrome.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Hypertension",
          "hypertension"
        ],
        [
          "Impaired Glucose Tolerance (IGT) / Type-2 Diabetes Mellitus (T2DM)",
          "presence of type 2 diabetes mellitus"
        ],
        [
          "Impaired Glucose Tolerance (IGT) / Type-2 Diabetes Mellitus (T2DM)",
          "impaired glucose tolerance"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "duration of Cushing's syndrome",
        "type of Cushing's syndrome (e.g., pituitary, adrenal, ectopic)",
        "history of hypothyroidism or hyperthyroidism",
        "renal function (e.g., estimated glomerular filtration rate)",
        "prior treatments for Cushing's syndrome"
      ]
    }
  }
}